SMLR Semler Scientific Inc Projected Price to Earnings

Corporate company logo of Semler (SMLR)

Semler Scientific, Inc. (SMLR) develops vascular analysis systems, while outsourcing the production of hardware modules and global services to third-party contractors. Market price action indicates that the current P/E ratio is 0.00. Market capitalization growth is supported by the sale of diagnostic complexes and the aggressive acquisition of cryptocurrency for the balance sheet, while the potential of new software is only beginning to unfold.

SMLR - semlerscientific.com Market Cap to Projected Earnings over the range 07/04/2022 - 01/31/2026

Financial and market metric breakdowns for Semler (SMLR)

- stock value and consensus price forecast:
Price Chart Semler Scientific|SMLR - Analyst Median Target
- market capitalization data:
Market Valuation Semler Scientific Inc|SMLR - Aggregate Business Value
- issuer book value statistics:
Book Value per Share Semler Scientific|SMLR - Book Valuation of Business|Market Capitalization to Book Value Ratio semlerscientific.com|SMLR - Cumulative Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Semler Scientific, Inc.|SMLR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Semler Scientific, Inc.|SMLR - Company Total Debt|Debts to Book Capitalization Semler Scientific Inc|SMLR - Long-Term Debt|Company Short-Term Debts Semler Scientific|Quick Ratio semlerscientific.com
- earnings and market ratios statistics:
SMLR - Net Financial Result|Projected Future Earnings Semler Scientific, Inc.|SMLR - Price to Earnings Ratio|Forward P/E Multiple Semler Scientific Corp|SMLR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Semler Scientific Inc|SMLR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Semler Scientific|SMLR - Earnings per share for the trailing year|Quarterly EPS earnings growth semlerscientific.com|SMLR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Semler Scientific, Inc.
Fundamental company analysis:Semler Scientific
Product sample of Semler Scientific, Inc.

It is critical for investors to timely identify the risk of overpaying for Semler Scientific, Inc. (SMLR) shares. Robotic manufacturing ensures high vascular diagnostic precision, which minimizes defects and stabilizes margins. The forward P/E trend for Semler Scientific, Inc. (SMLR) reflects the ratio of the current price to projected earnings, allowing for the daily tracking of the asset's fair value. This indicator helps avoid overvaluation without missing growth phases. The business's technological resilience confirms the reliability of these forecasts.

Competitors of Semler Scientific, Inc. (SMLR)

Future Price to Earnings Abbott (ABT)|Market Cap to Projected Earnings Thermo Fisher Scientific Inc.|GE Healthcare Corp - Projected Price to Earnings|Market Cap to Future Earnings Ratio MTD (Mettler Toledo Inc)|Waters Corporation - Forward P/E Multiple|Market Cap to Projected Earnings bio-techne.com TECH|BRKR: Forward P/E Multiple|Projected Price to Earnings Azenta Inc|Projected Price to Earnings VREX|BFLY: Future Price to Earnings Multiple|Future Price to Earnings Mesa Laboratories, Inc. (MLAB)|Projected Price to Earnings quantum-si.com QSI|Forward P/E Multiple NNOX (Nano-X)|Quanterix Corp. (QTRX) - Projected Price to Earnings Ratio|908 Devices Corp - Forward P/E Multiple|CV (CapsoVision Inc) - Price to Future Earnings Ratio|MXCT: Forward P/E Multiple|RPID - Market Cap to Projected Earnings|SEER (Seer) - Forward P/E Multiple|Projected Price to Earnings Hyperfine Inc (HYPR)|Forward P/E Multiple FONR|Forward P/E Multiple daxor.com (DXR)|Future Price to Earnings Spectral AI MDAI|organovo.com - Future Price to Earnings|ACON: Projected Price to Earnings|Future Price to Earnings Multiple AKYA (Akoya Biosciences)|THMO: Forward P/E Multiple|Projected Price to Earnings Ratio Talis Biomedical Corporation (TLIS)|Future Price to Earnings T2 Biosystems, Inc.